Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Novartis will acquire Corthera for $120 million and up to $500 million in development, regulatory and commercial milestones. Novartis will gain Corthera's relaxin, a recombinant human relaxin-H2 in P...